327705
E-cigarettes: Piecing together the regulatory puzzle
In 2014, the FDA issued proposed regulations for e-cigarettes, but there is no timetable as to when these rules may be finalized. Until that time, e-cigarettes exist in a federal regulatory void. In addition, as proposed, the regulations would not provide a comprehensive regulatory structure. As a result of the patchwork of state and local regulations, in many parts of the country, e-cigarettes, which typically contain highly-addictive nicotine, can be purchased by anyone, regardless of age, and are not subject to other laws that pertain to tobacco products.
Over the past several years, many states and local governments have taken steps to include e-cigarettes in their youth access, licensing, tax, product packaging and smoke-free laws, but the overall regulatory landscape is haphazard, at best.
This session will describe the proposed FDA deeming regulation, identify areas of coverage as well as gaps, and discuss the process by which the rule could become final. It will also identify options for state and local governments to regulate e-cigarettes to create a more uniform regulatory structure. Finally, it will discuss some of the policies that have been enacted in jurisdictions throughout the country.
Learning Areas:
Public health or related laws, regulations, standards, or guidelinesPublic health or related public policy
Learning Objectives:
Describe the federal regulatory process as it relates to e-cigarettes, identify key gaps and discuss options for state and local governments to fill in those gaps.
Keyword(s): Tobacco Control, Policy/Policy Development
Qualified on the content I am responsible for because: I am an attorney and public health policy expert. I have presented to a wide range of audiences at conferences throughout the country on issues related to e-cigarette regulation. In addition, I have provided legal technical assistance to over 30 states and many communities on proposed e-cigarette legislation.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.